Clofazimine: all 23 studies that test it
Page 1 of 1. Open to participants first (3), then studies with results posted, then the rest; newest registration first within each.
- Testing a Novel Combination Treatment (Arm D) Versus Standard of Care for Intensive Phase Treatment for Mycobacterium Abscessus Pulmonary Disease in People With or Without Cystic Fibrosis in the Finding the Optimal Regimen for Mycobacterium Abscessus Treatment (FORMaT) Adaptive Platform TrialNot yet recruitingNCT07485010Phase 2
- Bacteriophage Therapy for Mycobacterium Abscessus Pulmonary InfectionEnrolling by invitationNCT07228702Phase 1
- Finding the Optimal Regimen for Mycobacterium Abscessus TreatmentRecruitingNCT04310930Phase 2/3
- Ultra-Short Course Bedaquiline, Clofazimine, Pyrazinamide and Delamanid Versus Standard Therapy for Drug-Susceptible TuberculosisActive, not recruitingNCT05556746Phase 2Results posted
- Clofazimine- and Rifapentine-Containing Treatment Shortening Regimens in Drug-Susceptible Tuberculosis: The CLO-FAST StudyTerminatedNCT04311502Phase 2Results posted
- The Evaluation of a Standard Treatment Regimen of Anti-tuberculosis Drugs for Patients With MDR-TBCompletedNCT02409290Phase 3Results posted
- Evaluation of Early Bactericidal Activity in Pulmonary Tuberculosis With Clofazimine (C)-TMC207 (J)-PA-824 (Pa)-Pyrazinamide (Z)CompletedNCT01691534Phase 2Results posted
- Innovating Shorter, All- Oral, Precised Treatment Regimen for Rifampicin Resistant Tuberculosis：BDLL Chinese CohortActive, not recruitingNCT06649721Phase 3
- Pharmacokinetic Study With a Loading Dose of Clofazimine in Adult Patients With Nontuberculous Mycobacterial DiseaseCompletedNCT05294146Phase 2
- Refining MDR-TB Treatment (T) Regimens (R) for Ultra(U) Short(S) Therapy(T)-PLUSCompletedNCT04717908Not applicable
- Dual Therapy With Interferon Beta-1b and Clofazimine for COVID-19Status unknownNCT04465695Phase 2
- Economic Evaluation of New MDR TB RegimensCompletedNCT04207112Phase 2/3
- PRACTECAL-PKPD Sub StudyStatus unknownNCT04081077Phase 2/3
- Evaluating Newly Approved Drugs in Combination Regimens for Multidrug-Resistant TB With Fluoroquinolone Resistance (endTB-Q)CompletedNCT03896685Phase 3
- Efficacy and Tolerability of Bedaquiline, Delamanid, Levofloxacin, Linezolid, and Clofazimine to Treat MDR-TBActive, not recruitingNCT03828201Phase 2
- Two-month Regimens Using Novel Combinations to Augment Treatment Effectiveness for Drug-sensitive TuberculosisCompletedNCT03474198Phase 2/3
- A Phase 2A Evaluation of the Safety, Tolerability, Pharmacokinetics, Efficacy of Clofazimine (CFZ) in CryptosporidiosisTerminatedNCT03341767Phase 2
- Clofazimine in the Treatment of Pulmonary Mycobacterium Avium Complex (MAC)Active, not recruitingNCT02968212Phase 2
- Evaluating Newly Approved Drugs for Multidrug-resistant TBCompletedNCT02754765Phase 3
- Effect of Additional Clofazimine on Erythema Nodosum Leprosum (ENL) Reactions in LeprosyCompletedNCT01290744Phase 4
- The Safety and Effectiveness of Clarithromycin Plus Ethambutol Used With or Without Clofazimine in the Treatment of MAC in Patients With AIDSCompletedNCT00002331Not applicable
- A Randomized Controlled Prophylactic Study of Clofazimine To Prevent Mycobacterium Avium Complex Infection in HIV DiseaseCompletedNCT00002058Not applicable
- A Phase II/III Trial of Rifampin, Ciprofloxacin, Clofazimine, Ethambutol, and Amikacin in the Treatment of Disseminated Mycobacterium Avium Infection in HIV-Infected Individuals.CompletedNCT00000641Phase 2